4WM
AURA icon

49 Wealth Management’s Aura Biosciences AURA Stock Holding History

49 Wealth Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
21,704
+2,720
+14% +$15.6K 0.01% 193
2025
Q4 		$103K Buy
18,984
+8,375
+79% +$49.7K 0.01% 191
2025
Q3 		$65.6K Buy
+10,609
New +$69.4K 0.01% 193

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

49 Wealth Management's AURA Position: Q1 2026 in Review

49 Wealth Management increased its Aura Biosciences (AURA) stake by 14% in Q1 2026, buying an estimated $15.6K and bringing the position to 21,704 shares worth $145K. The position accounts for 0.01% of the portfolio, ranked #193.

49 Wealth Management first reported a position in AURA in Q3 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • 49 Wealth Management held 21,704 shares of Aura Biosciences worth $145K as of Q1 2026.
  • 49 Wealth Management bought 2,720 Aura Biosciences shares in Q1 2026, an estimated $15.6K.
  • Aura Biosciences made up 0.01% of 49 Wealth Management's portfolio in Q1 2026, its #193 holding.
  • 49 Wealth Management first reported a position in Aura Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on 49 Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.